Big Move For uniQure N.V.
Tue, Dec 10, 2024 at 07:06 PM
uniQure N.V. (QURE:NASDAQ) rocketted at $15.3, a gain of 109.7%. On Tue, Dec 10, 2024, QURE:NASDAQ hit a New 2-Week High of $15.3. The stock got featured on our News Catalysts scanner on Tue, Dec 10, 2024 at 02:45 PM in the 'MISCELLANEOUS' category. From Tue, Nov 26, 2024, the stock recorded 44.44% Up Days and 50.00% Green Days
About uniQure N.V. (QURE:NASDAQ)
uniQure NV is engaged in the field of gene therapy platform across three therapeutic focus areas: Liver/Metabolic Disease, Central Nervous System (CNS) Disease and Cardiovascular Disease.
Top 10 Gainers:
- Chimerix, Inc. (CMRX:NASDAQ), 219.08%
- uniQure N.V. (QURE:NASDAQ), 109.73%
- MSP Recovery Inc. (LIFW:NASDAQ), 103.77%
- Cumberland Pharmaceuticals Inc. (CPIX:NASDAQ), 96.77%
- Roadzen Inc Ord Cl A (RDZN:NASDAQ), 57.58%
- Cardiff Oncology Inc. (CRDF:NASDAQ), 54.92%
- Banzai International, Inc. Class A Common Stock (BNZI:NASDAQ), 47.48%
- SEALSQ Corp. (LAES:NASDAQ), 45.96%
- Falcon's Beyond Global, Inc. (FBYD:NASDAQ), 45.54%
- Rigetti Computing Inc. (RGTI:NASDAQ), 45.19%